Jean-Charles Soria to Sulfoxides
This is a "connection" page, showing publications Jean-Charles Soria has written about Sulfoxides.
Connection Strength
0.682
-
Phase I dose-escalation studies of roniciclib, a pan-cyclin-dependent kinase inhibitor, in advanced malignancies. Br J Cancer. 2017 Jun 06; 116(12):1505-1512.
Score: 0.682